We are live on
!
Find out more
BFM
Boston Financial Management Portfolio holdings
AUM
$3.31B
1-Year Est. Return
19.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$648M
AUM Growth
–
Cap. Flow
+$656M
Cap. Flow
% of AUM
101.29%
Top 10 Holdings %
Top 10 Hldgs %
30.29%
Holding
199
New
199
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$67M |
| 2 |
ExxonMobil
XOM
|
+$23M |
| 3 |
IBM
IBM
|
+$21.7M |
| 4 |
Johnson & Johnson
JNJ
|
+$15.5M |
| 5 |
Procter & Gamble
PG
|
+$14M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.15% |
| 2 | Consumer Staples | 11.73% |
| 3 | Energy | 11.08% |
| 4 | Technology | 10.95% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$142B
| $64.4M | 9.95% |
+2,424,540
| New | +$67M |
|
|
2
ExxonMobil
XOM
$651B
| $23.1M | 3.57% |
+255,863
| New | +$23M |
|
|
3
IBM
IBM
$209B
| $20.4M | 3.15% |
+111,528
| New | +$21.7M |
|
|
4
Johnson & Johnson
JNJ
$617B
| $15.7M | 2.42% |
+182,569
| New | +$15.5M |
|
|
5
Procter & Gamble
PG
$335B
| $13.7M | 2.11% |
+177,838
| New | +$14M |
|
6
AbbVie
ABBV
$455B
| $13.1M | 2.02% |
+316,157
| New | +$13.8M |
|
7
Automatic Data Processing
ADP
$105B
| $12.3M | 1.9% |
+203,290
| New | +$12.1M |
|
8
Emerson Electric
EMR
$83.3B
| $12.2M | 1.88% |
+222,786
| New | +$12.5M |
|
9
Abbott
ABT
$183B
| $10.9M | 1.68% |
+312,754
| New | +$11.5M |
|
10
GE Aerospace
GE
$368B
| $10.5M | 1.62% |
+94,526
| New | +$10.5M |
|
11
PepsiCo
PEP
$191B
| $9.56M | 1.48% |
+116,902
| New | +$9.55M |
|
|
APC
12
DELISTED
Anadarko Petroleum
APC
| $9.51M | 1.47% |
+110,640
| New | +$9.52M |
|
13
Microsoft
MSFT
$3.35T
| $8.61M | 1.33% |
+249,132
| New | +$8.16M |
|
14
Intel
INTC
$460B
| $8.45M | 1.31% |
+348,886
| New | +$8.24M |
|
15
American Express
AXP
$228B
| $8.18M | 1.26% |
+109,437
| New | +$7.79M |
|
16
McDonald's
MCD
$191B
| $8.12M | 1.25% |
+82,057
| New | +$8.22M |
|
17
Union Pacific
UNP
$172B
| $7.21M | 1.11% |
+93,518
| New | +$7.05M |
|
18
CVS Health
CVS
$134B
| $7.13M | 1.1% |
+124,750
| New | +$7.23M |
|
19
Costco
COST
$423B
| $7.02M | 1.08% |
+63,523
| New | +$6.94M |
|
20
3M
MMM
$90.8B
| $6.97M | 1.08% |
+76,251
| New | +$6.92M |
|
21
JPMorgan Chase
JPM
$933B
| $6.85M | 1.06% |
+129,833
| New | +$6.6M |
|
22
Diageo
DEO
$49.5B
| $6.65M | 1.03% |
+57,820
| New | +$6.99M |
|
23
SLB Ltd
SLB
$72.6B
| $6.64M | 1.03% |
+92,681
| New | +$6.86M |
|
24
RTX Corp
RTX
$289B
| $6.54M | 1.01% |
+111,796
| New | +$6.61M |
|
25
Apple
AAPL
$4.9T
| $6.5M | 1% |
+459,368
| New | +$7.07M |
|
Similar funds
CANY
MWM
CCM
ECG
LSAG
KL
WP
RDIA
Boston Financial Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Boston Financial Management, which disclosed 199 positions worth $648M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Pfizer: 2,424,540 shares worth $64.4M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Consumer Staples and Energy.
- Boston Financial Management's largest Q2 2013 buy was Pfizer: 2,424,540 shares worth $64.4M.
- Boston Financial Management's ten largest holdings make up 30% of its $648M portfolio in Q2 2013.
- Boston Financial Management disclosed 199 positions in Q2 2013, its first 13F filing on record.
Based on Boston Financial Management's 13F filing for Q2 2013, filed 19 Aug 2013.